文献速递慢性肾脏病血液净化与透析

肾衰竭风险方程:在59个队列中评估包括使用CKD-EPI 2021方程估算的eGFR在内的新输入变量

The Kidney Failure Risk Equation: Evaluation of Novel Input Variables including eGFR Estimated Using the CKD-EPI 2021 Equation in 59 Cohorts.
PubMed 文献 · J Am Soc Nephrol · 2023-01-26

该研究利用59个队列共312,424例慢性肾脏病患者,评估肾衰竭风险方程(KFRE)使用CKD-EPI 2021肌酐方程估算eGFR时的预测性能与校准度,并检验改用1年平均ACR、1年平均eGFR、加入2年前eGFR斜率与心血管合并症或竞争风险模型能否改善表现;结果显示KFRE总体准确,其他修改未改善性能,仅在eGFR 45-59 ml/min per 1.73 m²及老年人群5年时域分别出现系统性低估与高估。

要点

  • 在59个队列312,424例CKD患者中,使用CKD-EPI 2021方程估算eGFR时KFRE总体保持准确且校准良好。
  • 改用1年平均ACR、1年平均eGFR、加入2年前eGFR斜率及心血管合并症均未改善KFRE性能。
  • eGFR 45-59 ml/min per 1.73 m²亚组出现系统性低估,老年人群5年时域出现系统性高估。

核心结论

  • 使用CKD-EPI 2021方程时,原始KFRE对eGFR<45 ml/min per 1.73 m²的人群总体准确。
  • 纳入竞争风险方法与eGFR样条项可能改善低风险、较长时域场景的校准度。
  • 在多数情况下,纳入历史平均值、eGFR斜率或竞争风险设计未实质性改变KFRE性能。

研究设计与样本

  • 研究使用59个队列共312,424例慢性肾脏病患者,测试多种KFRE修改方案对改善性能的潜力。

主要发现

  • 使用CKD-EPI 2021 eGFR方程时,KFRE总体保持准确且校准良好。
  • 改用1年平均ACR替代单次ACR、在高eGFR变异参与者中使用1年平均eGFR、加入2年前eGFR斜率及心血管合并症均未改善KFRE性能。
  • 在eGFR 45-59 ml/min per 1.73 m²亚组中,KFRE出现系统性低估。
  • 在老年人群使用5年时域时,KFRE出现系统性高估。
  • 新开发的包含eGFR样条项并纳入死亡竞争风险的模型在这些特定亚组中校准更准确,但总体未改善。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

SIGNIFICANCE STATEMENT: The kidney failure risk equation (KFRE) uses age, sex, GFR, and urine albumin-to-creatinine ratio (ACR) to predict 2- and 5-year risk of kidney failure in populations with eGFR <60 ml/min per 1.73 m 2 . However, the CKD-EPI 2021 creatinine equation for eGFR is now recommended for use but has not been fully tested in the context of KFRE. In 59 cohorts comprising 312,424 patients with CKD, the authors assessed the predictive performance and calibration associated with the use of the CKD-EPI 2021 equation and whether additional variables and accounting for the competing risk of death improves the KFRE's performance. The KFRE generally performed well using the CKD-EPI 2021 eGFR in populations with eGFR <45 ml/min per 1.73 m 2 and was not improved by adding the 2-year prior eGFR slope and cardiovascular comorbidities. BACKGROUND: The kidney failure risk equation (KFRE) uses age, sex, GFR, and urine albumin-to-creatinine ratio (ACR) to predict kidney failure risk in people with GFR <60 ml/min per 1.73 m 2 . METHODS: Using 59 cohorts with 312,424 patients with CKD, we tested several modifications to the KFRE for their potential to improve the KFRE: using the CKD-EPI 2021 creatinine equation for eGFR, substituting 1-year average ACR for single-measure ACR and 1-year average eGFR in participants with high eGFR variability, and adding 2-year prior eGFR slope and cardiovascular comorbidities. We also assessed calibration of the KFRE in subgroups of eGFR and age before and after accounting for the competing risk of death. RESULTS: The KFRE remained accurate and well calibrated overall using the CKD-EPI 2021 eGFR equation. The other modifications did not improve KFRE performance. In subgroups of eGFR 45-59 ml/min per 1.73 m 2 and in older adults using the 5-year time horizon, the KFRE demonstrated systematic underprediction and overprediction, respectively. We developed and tested a new model with a spline term in eGFR and incorporating the competing risk of mortality, resulting in more accurate calibration in those specific subgroups but not overall. CONCLUSIONS: The original KFRE is generally accurate for eGFR <45 ml/min per 1.73 m 2 when using the CKD-EPI 2021 equation. Incorporating competing risk methodology and splines for eGFR may improve calibration in low-risk settings with longer time horizons. Including historical averages, eGFR slopes, or a competing risk design did not meaningfully alter KFRE performance in most circumstances.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Grams ME, Brunskill NJ, Ballew SH, et al. The Kidney Failure Risk Equation: Evaluation of Novel Input Variables including eGFR Estimated Using the CKD-EPI 2021 Equation in 59 Cohorts. J Am Soc Nephrol. 2023. PMID: 36857500. doi:10.1681/ASN.0000000000000050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。